Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Long term effects of low intensity pulsed focused ultrasound treatment with microbubbles on brain metabolism in a rat model.

Georgios Papadakis, Zsofia Kovacs, Tsang-Wei Tu, Siva Muthusamy, William Reid, Dianne Lee, Rafael Casas, Joseph Frank and Dima Hammoud
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1048;
Georgios Papadakis
3Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences National Institutes of Health (N.I.H.), Clinical Center (CC) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsofia Kovacs
2Frank Laboratory, Radiology and Imaging Sciences National Institutes of Health (N.I.H.) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsang-Wei Tu
2Frank Laboratory, Radiology and Imaging Sciences National Institutes of Health (N.I.H.) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siva Muthusamy
1National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Reid
3Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences National Institutes of Health (N.I.H.), Clinical Center (CC) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dianne Lee
3Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences National Institutes of Health (N.I.H.), Clinical Center (CC) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael Casas
3Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences National Institutes of Health (N.I.H.), Clinical Center (CC) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Frank
4Frank Laboratory, Radiology and Imaging Sciences National Institutes of Health (N.I.H.), Clinical Center (CC) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dima Hammoud
3Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences National Institutes of Health (N.I.H.), Clinical Center (CC) BETHESDA MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1048

Objectives Ultrasound techniques could serve as potential tools for blood brain barrier (BBB) disruption allowing delivery of therapeutic molecules to localized disease sites such as malignant brain tumors. However, there is lack of data regarding the molecular sequelae of these treatment strategies on brain functions such as glucose metabolism. The aim of our study was to determine the long-term effects of low intensity pulsed focused ultrasound treatment with microbubbles (pFUS+MB) on the metabolic activity of rat brains.

Methods A cohort of 6 female rats received one session of pFUS+MB (Optison TM, GE Healthcare, Little Chalfont, UK) targeting the left striatum and adjacent insular cortex. 200 μl of microbubbles were administered intravenously over 1 minute starting 30 sec before pFUS. 0.3 MPa acoustic pressure was applied in 10 ms burst length and 1% duty cycle (9 focal points, 120 sec/9 focal points - striatum, 120 sec/4 focal points - hippocampus) using a single-element spherical FUS transducer (center frequency: 589.636 kHz; focal number: 0.8; aperture: 7.5 cm; FUS Instruments, Toronto, Ontario, Canada). T1-weighted gadolinium-enhanced images were obtained using 3.0 T MRI (Philips, Amsterdam, Netherlands), immediately after pFUS+MB. The animals underwent static brain 18F-FDG microPET/CT studies at 6 and 12 weeks post treatment. The animals were fasted for at least 6 hours before receiving 0.7 - 0.9 mCi of 18F-FDG via tail vein injection, while anesthetized. Subsequently, the animal was allowed to regain consciousness for an uptake period of 30 minutes in total, and then was anesthetized and scanned using Inveon Multimodality PET/CT scanner (Siemens Medical Solutions USA, Inc.). CT scan was performed for localization and attenuation correction purposes. SUV values were obtained from volumes of interest (VOI) corresponding to the sonicated left striatum/insular cortex, and contralateral brain (green contours in Fig 1b). The ratios of uptake (ipsilateral/contralateral) were then calculated.

Results Enhanced T1-weighted MRI scans performed immediately after pFUS+MB showed contrast enhancement in the targeted brain regions (left striatum and adjacent insular cortex), suggestive of BBB disruption (arrows in Fig. 1a). 18F-FDG microPET/CT studies performed at 6 and 12 weeks after the initial treatment with pFUS+MB did not reveal glucose metabolism discrepancies between ipsilateral (targeted) and contralateral brain upon qualitative evaluation. The ratios of SUV values (ipsilateral/contralateral) were 0.993 (0.017) at 6 weeks and 0.994 (0.007) at 12 weeks (Fig. 1b). There were no statistically significant differences between the two sides.

Conclusions Low intensity pFUS+MB does not cause long-term changes in rat brain metabolic activity at 6 and 12 weeks after sonication. Those findings suggest preserved neuronal integrity and function in the sonicated brain regions. However, the short-term effects (24h, 3 days, 1 week) as well as the effects of repeated pFUS+MB treatments need to be further explored.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long term effects of low intensity pulsed focused ultrasound treatment with microbubbles on brain metabolism in a rat model.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Long term effects of low intensity pulsed focused ultrasound treatment with microbubbles on brain metabolism in a rat model.
Georgios Papadakis, Zsofia Kovacs, Tsang-Wei Tu, Siva Muthusamy, William Reid, Dianne Lee, Rafael Casas, Joseph Frank, Dima Hammoud
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1048;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Long term effects of low intensity pulsed focused ultrasound treatment with microbubbles on brain metabolism in a rat model.
Georgios Papadakis, Zsofia Kovacs, Tsang-Wei Tu, Siva Muthusamy, William Reid, Dianne Lee, Rafael Casas, Joseph Frank, Dima Hammoud
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1048;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

  • Development of 2-[18F]trifluoromethyl-L-tryptophan (2-[18F]CF3-L-Trp) for serotonergic system imaging
  • Discovery of a novel radioligand [11C] AS2471907 for PET imaging of the brain 11β-HSD1
Show more SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire